These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11583897)

  • 1. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.
    Pires LA; Lehmann MH; Buxton AE; Hafley GE; Lee KL;
    J Am Coll Cardiol; 2001 Oct; 38(4):1156-62. PubMed ID: 11583897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction.
    Pires LA; Hafley GE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Buxton AE;
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):757-63. PubMed ID: 12212692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
    Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis.
    Wyse DG; Talajic M; Hafley GE; Buxton AE; Mitchell LB; Kus TK; Packer DL; Kou WH; Lemery R; Santucci P; Grimes D; Hickey K; Stevens C; Singh SN
    J Am Coll Cardiol; 2001 Aug; 38(2):344-51. PubMed ID: 11499722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
    Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
    Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of nonsustained ventricular tachycardia after revascularization.
    Mittal S; Lomnitz DJ; Mirchandani S; Stein KM; Markowitz SM; Slotwiner DJ; Iwai S; Das MK; Lerman BB
    J Cardiovasc Electrophysiol; 2002 Apr; 13(4):342-6. PubMed ID: 12033350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MUSTT study: evaluating testing and treatment.
    Klein HU; Reek S
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():45-50. PubMed ID: 10590488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Fisher JD; Buxton AE; Lee KL; Packer DL; Echt DS; Denes P; Lehmann MH; DiMarco JP; Roy D; Hafley GE;
    Am J Cardiol; 2007 Jul; 100(1):76-83. PubMed ID: 17599445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy.
    Piers SR; Androulakis AF; Yim KS; van Rein N; Venlet J; Kapel GF; Siebelink HM; Lamb HJ; Cannegieter SC; Man SC; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e009979. PubMed ID: 35089806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification for serious arrhythmic events using nonsustained ventricular tachycardia and heart rate turbulence detected by 24-hour holter electrocardiograms in patients with left ventricular dysfunction.
    Miwa Y; Yoshino H; Hoshida K; Miyakoshi M; Tsukada T; Yusu S; Ikeda T
    Ann Noninvasive Electrocardiol; 2012 Jul; 17(3):260-7. PubMed ID: 22816545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing Risk Factors in Pediatric Patients With Pacemakers Implanted for Atrioventricular Block: The Impact of Nonsustained Ventricular Tachycardia.
    Niu MC; Morris SA; Krenek M; DE LA Uz CM; Pedroza C; Miyake CY; Kim JJ; Valdés SO
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):471-9. PubMed ID: 27074776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
    Buxton AE; Lee KL; Hafley GE; Pires LA; Fisher JD; Gold MR; Josephson ME; Lehmann MH; Prystowsky EN;
    J Am Coll Cardiol; 2007 Sep; 50(12):1150-7. PubMed ID: 17868806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Piccini JP; Hafley GE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Buxton AE;
    J Cardiovasc Electrophysiol; 2009 Aug; 20(8):850-5. PubMed ID: 19490266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study.
    Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.